Anti-Xylazine- (Clone XYL-8536)

Specificity: Anti-Xylazine (Clone XYL-8536) has the following specificity: Xylazine - 100%, 3-Hydorxy Xylazine - 150%, 4-Hydroxy Xylazine - 180%, 4-Hydroxy Xylazine-O-Glucuronide - 200% Background: Background: Xylazine is a potent alpha-2 adrenergic agonist that was initially developed as a veterinary sedative and analgesic medication. Xylazine was not approved for human use and has been increasingly found in samples of illicit drugs like fentanyl. The increase in the detection of xylazine mixed with fentanyl has corresponded with an increase in overdose deaths. In 2023, fentanyl mixed with xylazine was declared an emerging threat by the White House?s Office of National Drug Control Policy.

Product Specifications

Target Antigen

Xylazine

Clonality

Monoclonal

Clone

XYL-8536

Applications

ELISA

Purification

Purity: >90% for SDS PAGE Preparation: This monoclonal antibody is purified by ion exchange chromatography.

Components

Concentration: >=1.0 mg/mL Formulation: Formulated in 0.015 M phosphate buffered saline (0.85%), pH 7.2 and contains 0.05% sodium azide. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.